- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
Patent holdings for IPC class A61P 21/00
Total number of patents in this class: 5658
10-year publication summary
|
115
|
118
|
237
|
340
|
332
|
375
|
500
|
543
|
550
|
447
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Dyne Therapeutics, Inc. | 253 |
96 |
| Société des Produits Nestlé S.A. | 9870 |
85 |
| Research Institute at Nationwide Children's Hospital | 580 |
82 |
| Sarepta Therapeutics, Inc. | 381 |
67 |
| Novartis AG | 10626 |
50 |
| Centre National de La Recherche Scientifique | 10666 |
48 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3369 |
47 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2967 |
47 |
| Osaka University | 3384 |
47 |
| Avidity Biosciences, Inc. | 186 |
42 |
| The Regents of the University of California | 20268 |
32 |
| Genethon | 260 |
30 |
| Takeda Pharmaceutical Company Limited | 2716 |
28 |
| Kyoto University | 2848 |
26 |
| F. Hoffmann-La Roche AG | 7934 |
25 |
| President and Fellows of Harvard College | 6030 |
25 |
| Daiichi Sankyo Company, Limited | 1880 |
23 |
| Edgewise Therapeutics, Inc. | 60 |
23 |
| Sorbonne Universite | 1331 |
22 |
| The Trustees of the University of Pennsylvania | 4376 |
21 |
| Other owners | 4792 |